Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase
Authors:
- John T. SiskoJSJohn T. Sisko
- Thomas J. TuckerTTThomas J. Tucker
- Mark T. BilodeauMBMark T. Bilodeau
- Carolyn A. BuserCBCarolyn A. Buser
- Patrice A. CieckoPCPatrice A. Ciecko
- Kathleen E. CollKCKathleen E. Coll
- Christine FernandesCFChristine Fernandes
- Jackson B. GibbsJGJackson B. Gibbs
- Timothy J. KoesterTKTimothy J. Koester
- Nancy KohlNKNancy Kohl
- Joseph J. LynchJLJoseph J. Lynch
- Xianzhi MaoXMXianzhi Mao
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (5) , 1146-1150
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion ChannelJournal of Medicinal Chemistry, 2004
- The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseBioorganic & Medicinal Chemistry Letters, 2004
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003
- Small Molecule Inhibitors of KDR (VEGFR-2) Kinase: An Overview of Structure Activity RelationshipsCurrent Topics in Medicinal Chemistry, 2002
- VEGF-Trap: A VEGF blocker with potent antitumor effectsProceedings of the National Academy of Sciences, 2002
- Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agentsExpert Opinion on Investigational Drugs, 2002
- Mechanisms of angiogenesisNature, 1997
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992